NCT01945554View on ClinicalTrials.gov

The Value of Short-term Pain Relief for the Prediction of Long-term Outcome After Cervical or Lumbar Nerve Root Infiltration

NACompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Cervical Disc HerniationLumbar Disc Herniation

Interventions

PROCEDURE

Cervical nerve root infiltration

4mg Mephamesone followed by 1ml of 0.5% bupivacaine (Bupivacain®) will be administered.

PROCEDURE

Lumbar nerve root infiltration

40mg triamzinolone (Kenacort®) followed by 2ml of 0.5% bupivacaine (Bupivacain®) will be administered.

DRUG

Mephamesone

DRUG

0.5% bupivacaine (Bupivacain®)

DRUG

Kenacort®

Trial Locations (3)

9007

Cantonal Hospital St. Gallen, Sankt Gallen

9230

Flawil Hospital, Flawil

9400

Rorschach Hospital, Rorschach

All Listed Sponsors

lead

Holger Joswig

OTHER

NCT01945554 - The Value of Short-term Pain Relief for the Prediction of Long-term Outcome After Cervical or Lumbar Nerve Root Infiltration | Biotech Hunter | Biotech Hunter